Status:
COMPLETED
Hydrogen Sulfide and Peripheral Arterial Disease
Lead Sponsor:
Louisiana State University Health Sciences Center Shreveport
Conditions:
Peripheral Arterial Disease
Eligibility:
All Genders
40+ years
Brief Summary
This will be an observational study comparing the plasma levels of free hydrogen sulfide in patients with and without peripheral arterial disease using a novel recently published method of measuring h...
Detailed Description
The investigators will conduct an observational cohort study to evaluate H2S levels in three groups of patients: 1. Patients without PAD as defined by ABI\>0.9 and \<1.3. 2. Patients with asymptomati...
Eligibility Criteria
Inclusion
- Patient scheduled at the cardiac catheterization laboratory for coronary or peripheral angiography.
- Age \> 40 years.
Exclusion
- Inability to provide informed consent.
- ST elevation myocardial infarction.
- Cardiogenic shock.
- Non-atherosclerotic PAD (e.g. Buerger's disease).
- Pregnant or nursing.
- Enrolment in another clinical trial requiring use of experimental therapeutic agents.
- ABI \> 1.3(indicative of non-compressible vessel needing further evaluation to diagnose PAD), unless documented known PAD.
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
252 Patients enrolled
Trial Details
Trial ID
NCT01407172
Start Date
August 1 2011
End Date
June 1 2012
Last Update
April 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LSUHSC Shreveport
Shreveport, Louisiana, United States, 71130